Prognostic value of serum [beta]2-microglobulin in HIV infection

Pedreira J, Castro A, Pereiro C, Barbuzano C, Krämer A, Goedert JJ, Wachter H, Fuchs D, Domingo P, Martinez E, Martinez C, et al. (1992)
The Lancet 340(8815): 370-372.

Download
OA
Journal Article | Published | English
Author
; ; ; ; ; ; ; ; ; ; ;
All
Publishing Year
ISSN
PUB-ID

Cite this

Pedreira J, Castro A, Pereiro C, et al. Prognostic value of serum [beta]2-microglobulin in HIV infection. The Lancet. 1992;340(8815):370-372.
Pedreira, J., Castro, A., Pereiro, C., Barbuzano, C., Krämer, A., Goedert, J. J., Wachter, H., et al. (1992). Prognostic value of serum [beta]2-microglobulin in HIV infection. The Lancet, 340(8815), 370-372.
Pedreira, J., Castro, A., Pereiro, C., Barbuzano, C., Krämer, A., Goedert, J. J., Wachter, H., Fuchs, D., Domingo, P., Martinez, E., et al. (1992). Prognostic value of serum [beta]2-microglobulin in HIV infection. The Lancet 340, 370-372.
Pedreira, J., et al., 1992. Prognostic value of serum [beta]2-microglobulin in HIV infection. The Lancet, 340(8815), p 370-372.
J. Pedreira, et al., “Prognostic value of serum [beta]2-microglobulin in HIV infection”, The Lancet, vol. 340, 1992, pp. 370-372.
Pedreira, J., Castro, A., Pereiro, C., Barbuzano, C., Krämer, A., Goedert, J.J., Wachter, H., Fuchs, D., Domingo, P., Martinez, E., Martinez, C., Fuster, M., Cortes, M., Sambeat, M.A., Ris, J., Cadafalch, J.: Prognostic value of serum [beta]2-microglobulin in HIV infection. The Lancet. 340, 370-372 (1992).
Pedreira, J., Castro, A., Pereiro, C., Barbuzano, C., Krämer, Alexander, Goedert, James J., Wachter, Helmut, Fuchs, Dietmar, Domingo, Pere, Martinez, Esteban, Martinez, Cecilia, Fuster, Monserrat, Cortes, Mariano, Sambeat, Maria A., Ris, Josep, and Cadafalch, Josep. “Prognostic value of serum [beta]2-microglobulin in HIV infection”. The Lancet 340.8815 (1992): 370-372.
Main File(s)
File Name
Access Level
OA Open Access

This data publication is cited in the following publications:
This publication cites the following data publications:

1 Citation in Europe PMC

Data provided by Europe PubMed Central.

Beta-2 microglobulin as a predictor of prognosis in HIV-infected men with haemophilia: a proposed strategy for use in clinical care.
Sabin CA, Phillips AN, Lee CA, Elford J, Timms A, Bofill M, Janossy G., Br. J. Haematol. 86(2), 1994
PMID: 7911035

13 References

Data provided by Europe PubMed Central.

Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
Mulder JW, Krijnen P, Coutinho RA, Bakker M, Goudsmit J, Lange JM., Genitourin Med 67(3), 1991
PMID: 1906425
The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals
bas, j aids 5(), 1992
Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection
kramer, j aids 2(), 1989
Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection.
Fuchs D, Spira TJ, Hausen A, Reibnegger G, Werner ER, Felmayer GW, Wachter H., Clin. Chem. 35(8), 1989
PMID: 2635886
A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
Stein SF, Evatt BL, McDougal JS, Lawrence DN, Holman RC, Ramsey RB, Spira TJ., Blood 66(4), 1985
PMID: 2994784
beta2-Microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various mitogens.
Kin K, Kasahara T, Itoh Y, Sakurabayashi I, Kawai T, Morita M., Immunology 36(1), 1979
PMID: 84785
Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
Fuchs D, Kramer A, Reibnegger G, Werner ER, Dierich MP, Goedert JJ, Wachter H., Infection 19 Suppl 2(), 1991
PMID: 1673120
Markers for disease progression in intravenous drug users infected with HIV-1.
Zangerle R, Fuchs D, Reibnegger G, Fritsch P, Wachter H., AIDS 5(8), 1991
PMID: 1685652
Beta 2-microglobulin levels in drug users: the influence of risk behaviour.
Flegg PJ, Brettle RP, Robertson JR, Clarkson RC, Bird AG., AIDS 5(8), 1991
PMID: 1777161
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA, Bacchetti P, Kolokathis A, Chaisson RE, Szabo S, Polsky B, Valainis GT, Mildvan D, Abrams D, Wilber J., BMJ 302(6768), 1991
PMID: 1671651
The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL, Taylor JM, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV., N. Engl. J. Med. 322(3), 1990
PMID: 1967191
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
Jacobson MA, Abrams DI, Volberding PA, Bacchetti P, Wilber J, Chaisson RE, Crowe S, Howard W, Moss A., J. Infect. Dis. 159(6), 1989
PMID: 2566637
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort
Moss, BMJ 296(6624), 1988

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 1353829
PubMed | Europe PMC

Search this title in

Google Scholar